Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Kestra Names Daniel Finney Vice President of Research & Development

$KMTSPress releaseSep 10, 2026, 6:00 AM ETRead the release

Kestra Medical Technologies named Daniel Finney Vice President of Research & Development and appointed him to the executive leadership team. He succeeds Phillip D. Foshee, Jr., who led Kestra's R&D organization from 2016 until his recent retirement and spearheaded development of the ASSURE WCD. Finney was promoted from Senior Director of New Product Development and brings more than 20 years of Class III medical device experience, with prior product development roles at Stryker, Physio-Control, and Medtronic.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    KMTS: Kestra Names Daniel Finney Vice President of Research & Development — AI Analysis | Signal8